Alterity Therapeutics Files 6-K for Security Quotation Application
Ticker: PRNAF · Form: 6-K · Filed: Jul 19, 2024 · CIK: 1131343
| Field | Detail |
|---|---|
| Company | Alterity Therapeutics Ltd (PRNAF) |
| Form Type | 6-K |
| Filed Date | Jul 19, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, securities, registration
Related Tickers: ATH
TL;DR
ATH filed a 6-K for a security quote application, check it out.
AI Summary
Alterity Therapeutics Limited filed a Form 6-K on July 19, 2024, to incorporate by reference its application for quotation of securities (Exhibit 99.1) into existing registration statements. This filing relates to the month of July 2024 and is being made by a foreign private issuer.
Why It Matters
This filing indicates a step towards potentially listing or trading additional securities, which could impact the company's capital structure and investor base.
Risk Assessment
Risk Level: low — The filing is procedural and incorporates an application for quotation, not a material event like an acquisition or earnings miss.
Key Players & Entities
- Alterity Therapeutics Limited (company) — Registrant
- July 19, 2024 (date) — Filing Date
- Exhibit 99.1 (document) — Application for quotation of securities
- ATH (ticker) — Security Ticker
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is being filed to incorporate by reference an application for quotation of securities (Exhibit 99.1) into existing registration statements.
What is the ticker symbol associated with the securities mentioned in Exhibit 99.1?
The ticker symbol associated with the securities is ATH.
Which registration statements is this Form 6-K being incorporated into?
This Form 6-K is being incorporated by reference into Alterity Therapeutics' Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, and 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, and 333-250076).
What is the principal executive office address of Alterity Therapeutics Limited?
The principal executive office is located at Level 14, 350 Collins Street, Melbourne, Victoria 3000, Australia.
Is Alterity Therapeutics Limited filing an annual report under Form 20-F or 40-F?
Alterity Therapeutics Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 191 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2024-07-19 06:22:39
Filing Documents
- ea0209700-6k_alterity.htm (6-K) — 13KB
- ea020970001ex99-1_alterity.htm (EX-99.1) — 38KB
- ex99-1_001.jpg (GRAPHIC) — 1KB
- 0001213900-24-062728.txt ( ) — 54KB
From the Filing
OF FOREIGN PRIVATE ISSUER SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-163 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Alterity Therapeutics Limited (Name of Registrant) Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F This Form 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073 , 333-248980 and 333-228671 ) and our Registration Statements on Form F-3 (Files No. 333-274816 , 333-251647 , 333-231417 and 333-250076 ) ALTERITY THERAPEUTICS LIMITED (a development stage enterprise) The following exhibits are submitted: 99.1 Application for quotation of securities - ATH 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alterity Therapeutics Limited By: /s/ Geoffrey P. Kempler Geoffrey P. Kempler Chairman Date: July 19, 2024 2